Clinical trial
Pacritinib Effectiveness in Real-world Settings (PACER)
NCT07774455 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pacritinib Effectiveness in Real-world Settings (PACER)
- Lead sponsor
- Swedish Orphan Biovitrum
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 13, 2026
- Completion date
- January 27, 2027
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
myelofibrosis (mf)